Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Delivering purposeful solutions at Obesity Week 2025

    October 9, 2025 | Obesity Week 

    We’re attending Obesity Week 2025, the world’s leading event dedicated to obesity research and care, to showcase how our integrated expertise is advancing progress in obesity and cardiometabolic health.

    - PMLiVE

    Obesity Week 2025 is the premier global event dedicated to obesity research, prevention, and care – bringing together leading scientists, clinicians, and innovators to advance progress in one of the most dynamic areas of healthcare.​

    At Inizio, we’re uniting science, strategy, and creativity to deliver purposeful solutions across obesity and cardiometabolic health. Our integrated teams collaborate across the full commercialization journey to help clients navigate complexity, unlock value, and enhance outcomes at every stage of development and delivery.​

    Our experience spans the full obesity ecosystem: we’ve supported over 20 leading anti-obesity therapies, partnered on 80% of the largest GLP-1 assets, and worked across 18 specialized services to deliver smarter, connected solutions that make an impact.​

    Visit us at booth #812 to meet our experts and explore how Inizio’s integrated expertise is transforming the future of obesity and cardiometabolic care.​

    If you’d like to meet with us at Obesity Week, please get in touch.

    This content was provided by Inizio

    Company Details

    - PMLiVE

    Inizio

    Email
    Website

     Latest Content from  Inizio 

    Summer Intern experience at Research Partnership

    We look for bright and inquisitive people who want to learn in a company that's pushing the boundaries of pharmaceutical market research

    Double win at Communiqué 2016: Pegasus scoops awards for Consultancy of the Year (for the second time!) and Excellence in Media Relations

    Pegasus, an Ashfield company, part of UDG Healthcare plc, is delighted to have won the prestigious Consultancy of the Year award at the 2016 Communiqué Awards in London. The judges...

    Beyond Andrology: Trends in Men’s Health in Emerging Markets

    Published in eyeforpharma July 2016 by Rachel Howard

    Pharma & life sciences division growth allows Pegasus to fill three new senior positions

    Pegasus has expanded its pharma & life sciences senior team by appointing a new Associate Director and promoting two members of the existing team to Account Directors.

    Infographic: HIV Market Snapshot

    Our latest HIV infographic, taken from data collected from syndicated tracking study Therapy Watch, reveals that more than 3 in 5 naive or switch patients are currently treated with a STR (single...

    Infographic: The vaccine opportunity in Asia

    As predicted, the vaccine market in emerging and developing countries has continued to expand. While the global vaccine market is expected to grow at around 12% annually over the next...

    Webinar: What next for biosimilars?

    Tuesday 19th July 15:00 BST/10:00 EDT/16:00 CEST

    Understanding the Patient Journey

    The patient journey is changing. Patients are now much more educated and engaged. They have access to information and want to be involved in decisions around their treatment programme.  Technology...

    Case Study: Oncology diagnostic biomarker landscaping study

    The challenge:Our client needed to understand moleculardiagnostic testing growth opportunities for a new biomarker in oncology. They wanted to understand the current market landscape, identify potential leverage points that would maximise use of the biomarker...

    Research Partnership publishes 2016 Living with RA reports

    Research Partnership has published new Living with rheumatoid arthritis (RA) EU and US market reports for 2016.